Bluejay Diagnostics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -49 | -48 | -31 | |
EBITDA | -2,273 | -1,869 | -1,380 | -1,565 |
EBIT | -2,324 | -1,919 | -1,429 | -1,597 |
Net Income | -2,324 | -1,919 | -1,429 | -1,597 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,642 | -1,608 | -1,628 | -1,359 |
Cash | 9,598 | 3,684 | 5,164 | 3,082 |
Basic Shares | 2,079 | 449 | 449 | 393 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $249 |
Gross Profit | -170 | -199 | -780 | 48 |
EBITDA | -6,676 | -6,695 | -9,172 | -8,990 |
EBIT | -6,847 | -6,894 | -9,953 | -9,296 |
Net Income | -6,848 | -7,717 | -9,953 | -9,296 |
Net Change In Cash | 0 | 0 | 0 | 249 |
Free Cash Flow | -6,227 | -8,126 | -9,018 | -8,940 |
Cash | 5,164 | 4,301 | 2,208 | 10,114 |
Basic Shares | 449 | 45 | 34 | 31 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.12 |
2026-03-31 | -$1.94 |
2025-12-31 | -$2.36 |
2025-09-30 | -$1.01 |